The 21st Awaji International Forum on Infection and Immunity

Session information

Poster

[P2] Poster Discussion 2 (Even Numbers)

Tue. Sep 5, 2023 1:50 PM - 2:50 PM Lecture Hall (Main Banquet Hall NAGANO)

Moses Lorenzo Akyeh1,2, Masatomo Morita3, Quynh Anh Pham Hong4, Hien Tran Thi4, Linh Tuyet Ngoc Pham4, , Nguyen Dong Tu Tu4, Taichiro Takemura Takemura4, Hiroyuki Terashima2, Hirataka Hiyoshi2, Toshio Kodama2 (1.Graduate School of Biomedical Sciences, Nagasaki University, 2.Dept of Bacteriology, Inst Trop Med, Nagasaki Univ, Nagasaki, Japan, 3.Dept of Bacteriology I, Nat Inst Infect Dis, Tokyo, Japan, 4.Vietnam Research Station, Inst Trop Med, Nagasaki Univ, Hanoi, Vietnam)

Brandon Malone1, Ioannis Vardaxis1, Boris Simovski1, Simen Tennoe1, Marius Gheorghe1, Agnieszka Gromadka1, Kousuke Onoue4, Yuki Tanaka4, Sebastian Kapell1, Pierre Machart3, Roman Volchenkov3, Onoguchi Kazuhide1, Richard Stratford4, Trevor Clancy1,2 (1.NEC OncoImmunity, Norway, 2.Institute of Tropical Medicine, Nagasaki University, Japan, 3.NEC Research Laboratories Europe, Germany, 4.NEC Corporation, Japan)

Rashmi R Dash1,2, Negishi Hideo3,4, Michelle SJ Lee1,4, Ken. J. Ishii3,4, Shiroh Iwanaga5, Cevayir Coban1,2,4 (1.Division of Malaria Immunology, Institute of Medical Science (IMSUT), University of Tokyo, 2.Graduate School of Frontier Science, University of Tokyo, 3.Division of Vaccine Science, IMSUT, University of Tokyo, 4.International Vaccine Design Center, IMSUT, University of Tokyo, 5.Department of Protozoology, RIMD, Osaka University)

Toshiki Eri1, Herve Blanc2, Thomas Bigot3, Malgorzata E. Mnich1, Pedro Goncalves1, Evangelia Eleftheriou1, Lionel Frangeul2, Darragh Duffy4, Jean-Laurent Casanova5,6,7,8, Maria-Carla Saleh2, James P. Di Santo1 (1.Innate Immunity Unit, Inserm U1223, Institut Pasteur, Paris, France, 2.Viruses and RNA Interference Unit, Institut Pasteur, CNRS, Paris, France, 3.Bioinformatic and Biostatistic Hub - Computational Biology Department, Institut Pasteur, Universite de Paris, Paris, France, 4.Translational Immunology Lab, Institut Pasteur, Paris, France, 5.Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France, 6.University of Paris, Imagine Institute, Paris, France, 7.St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA, 8.Howard Hughes Medical Institute, New York, NY, USA)

Su Myat Han1,2, Robert Alexis2, Endo Akira1,2, Baguelin Marc2,7, Saito Nobu4,5, Suzuki Motoi1,6, Masuda Shingo1,3, Kanda Satoshi3, Komori Kazuhiri3, Yasaka Takahiro3, Ariyoshi Koya4,5 (1.School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan, 2.Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK, 3.Department of Internal Medicine, Kamigoto Hospital, Kamigoto, Japan, 4.Department of Microbiology, Faculty of Medicine, Oita University, Yufu, Japan, 5.Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan, 6.Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan, 7.MRC Centre for Global Infectious Disease Analysis and the Abdul Latif Jameel Institute for Disease, London, UK)

Shuhei Higuchi1,2, Yafei Liu1,2, Shimizu Jun3, Ono Chikako4,5, Itoh Yumi6, Okamoto Toru6, Matsuura Yoshiharu4,5, Shioda Tatsuo7, Arase Hisashi1,2 (1.Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Japan, 2.Laboratory of Immunochemistry, WPI Immunology Frontier Research Center, Osaka University, Japan, 3.MiCAN Technologies, Inc., Japan, 4.Laboratory of Virus Control, Center for Infectious Disease Education and Research, Osaka University, Japan, 5.Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Japan, 6.Department of Microbiology, Juntendo University School of Medicine, Japan, 7.Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Japan)

Shangfan Hu1,2,3, Yoko Fujita-Fujiharu1,2,3, Yukihiko Sugita1,3,4, Lisa Wendt5, Yukiko Muramoto1,2,3, Masahiro Nakano1,2,3, Thomas Hoenen5, Takeshi Noda1,2,3 (1.Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, 2.Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University, 3.CREST, Japan Science and Technology Agency, 4.Hakubi Center for Advanced Research, Kyoto University, 5.Laboratory for Integrative Cell and Infection Biology, Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut)

Takehiro Kanda1,2, Santos Pauline3, Hoper Dirk3, Beer Martin3, Rubbenstroth Dennis3, Tomonaga Keizo1,2,4 (1.Laboratory of RNA viruses, Institute for Life and Medical Sciences, Kyoto University, Japan, 2.Department of Molecular Virology, Graduate School of Medicine, Kyoto University, Japan, 3.Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Germany, 4.Department of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto University, Japan)

Yuki Masuo1,2, Hiroyuki Yoshitomi1, Yoshitaka Honda1,3, Hajime Morita1, Shuhe Ma1,3, Takao Hashiguchi2,4, Akihiko Sugimoto5, Sachiko Minamiguchi5, Hironori Haga5, Tatsuya Kamitori6, Hideki Yokoi7, Takamoto Hirota8, Kinta Hatakeyama9, Yoshihiko Ikeda9, Keiko Ohta-Ogo9, Masanori Matsumoto10, Tomoya Hayashi11, Ken J. Ishii11, Fumihiro Fujiki12, Tadaki Suzuki13, Shun Iida13, Harutaka Katano13, Hideki Ueno1,2,3 (1.Department of Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 2.Kyoto University Immunomonitoring Center, Kyoto University, Kyoto, Japan, 3.ASHBi Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan, 4.Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan, 5.Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan, 6.Department of Pediatrics, Kyoto University Hospital, Kyoto, Japan, 7.Department of Nephrology, Kyoto University Hospital, Kyoto, Japan, 8.Department of Cardiology, Osaka Saiseikai Noe Hospital, Osaka, Japan, 9.Department of Pathology, National Cerebral and Cardiovascular Center Hospital, Suita, Japan, 10.Department of Hematology, Nara Medical University, Kashihara, Japan, 11.Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 12.Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Suita, Japan, 13.Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan)

Julia Matsuo-Dapaah1,2, Michelle S. J. Lee1,3, Manabu Ozawa4, Masahiro Yamamoto5, Ken J. Ishii3,6, Cevayir Coban1,2,3 (1.Division of Malaria Immunology, Institute of Medical Science, University of Tokyo, Japan, 2.Graduate School of Medicine, University of Tokyo, Japan, 3.International Vaccine Design Center, Institute of Medical Science, University of Tokyo, Japan, 4.Laboratory of Reproductive Systems Biology, Institute of Medical Science, University of Tokyo, Japan, 5.Department of Immunoparasitology, WPI Immunology Frontier Research Center, Osaka University, Japan, 6.Division of Vaccine Science, Institute of Medical Science, University of Tokyo, Japan)

Rayhane Nchioua1, Caterina Prelli-Bozzo1, Dorota Kmiec1, Fabian Zech1, Sabrina Noettger1, Annika Schundner2, Manfred Frick2, Steffen Just3, Konstantin M. J. Sparrer1, Frank Kirchhoff1 (1.Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany, 2.Institute of General Physiology, Ulm University, 3.Molecular Cardiology, Department of Internal Medicine II, Ulm University, Ulm, Germany)

Micheal T Pillay1,2, Noboru Minakawa1,3, Jayanthi V Ratnam4, Swadhin K Behera4, Nyakallo Kgalane5 (1.Institute of Tropical Medicine, Nagasaki University, 2.Graduate School of Biomedical Sciences, Nagasaki University, 3.Department of Vector Ecology and Environment, Institute of Tropical Medicine, Nagasaki University, 4.Application Laboratory, Japan Agency for Marine-Earth Science and Technology (JAMSTEC), 5.Limpopo Department of Health, Malaria Control)

David G Priest1, Janyerkye Tulyeu1,2, Jonas N Sondergaard1,2, Yuki Togami3, Yumi Mitsuyama4, Shuhei Sakakibara5, Takeshi Ebihara3, Hisatake Matsumoto3, Hiroshi Ogura3, James B Wing1,2 (1.Laboratory of Human Single Cell Immunology, iFReC, Osaka University, 2.Human Single Cell Immunology Team, CiDER, Osaka University, 3.Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, 4.Division of Trauma and Surgical Critical Care, Osaka General Medical Center, 5.Laboratory of Immune Regulation, iFReC, Osaka University)

Dianita S Saputri1, Hendra S Ismanto1, Dendi K Nugraha1, Zichang Xu2, Yasuhiko Horiguchi1,3, Shuhei Sakakibara2,4, Daron M Standley1,2,3 (1.Research Institute for Microbial Diseases, Osaka University, Japan, 2.Immunology Frontier Research Center, Osaka University, Japan, 3.Center for Infectious Disease Education and Research, Osaka University, Japan, 4.Graduate School of Medical Safety Management, Jikei University of Health Care Sciences, Japan)

Atsushi Shimoyama1, Yamaura Haruki1,2, Hosomi Koji2, Saika Azusa2, Di Lorenzo Flaviana3, Matamoros-Recio Alejandra4, Martin Santamaria Sonsoles1,4, Molinaro Antonio1,3, Kunisawa Jun1,2, Fukase Koichi1 (1.Graduate School of Science, Osaka University, 2.National Institutes of Biomedical Innovation, Health and Nutrition, 3.Department of Chemical Sciences, University of Naples Federico II, 4.Spanish National Research Council)

Sarunporn Tandhavanant1,2, Hiroyuki Terashima1, Dhira Saraswati Anggramukti3, Hirotaka Hiyoshi1, Narisara Chantratita2, Tetsuya Iida3, Shigeaki Matsuda3, Toshio Kodama1 (1.Department of Bacteriology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan, 852-8523, 2.Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, 10400, 3.Department of Bacteriology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan, 565-0871)

BURCU TEMIZOZ1,2, TAKAYUKI SHIBAHARA2,3, KOU HIOKI1, MICHELLE SUE JANN LEE5, NAZ SURUCU9, ERDAL SAG10, MASAHIRO YAMAMOTO4, CEVAYIR COBAN5,11, MAYDA GURSEL12, SEZA OZEN10, ETSUSHI KURODA13, ATSUSHI KUMANOGOH3,6,7,8, KEN J ISHII1,2,11 (1.Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 2.Laboratory of Mockup Vaccine, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan, 3.Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan, 4.Department of Immunoparasitology, Division of Infectious Disease, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan, 5.Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 6.Department of Immunopathology, WPI, Immunology Frontier Research Center (iFReC), Osaka University, Suita, Osaka, Japan, 7.Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Suita, Osaka, Japan, 8.Center for Infectious Diseases for Education and Research (CiDER), Osaka University, Suita, Osaka, Japan, 9.Department of Biological Sciences, Middle East Technical University (METU), Ankara, Turkey, 10.Department of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey, 11.International Vaccine Design Center (VDesC), The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, Japan, 12.Izmir Biomedicine and Genome Center, Izmir, Turkey, 13.Department of Immunology, School of medicine, Hyogo Medical University, Nishinomiya, Hyogo, Japan)

Asuka J Tobuse1, Kouji Kobiyama1,2, Jun Tsuchida1, Teppei Hara1, Masamitsu Asaka3, Daichi Utsumi3, Tomoya Hayashi1, Burcu Temizoz1, Hideo Negishi1, Yasuhiro Yasutomi3, Ken J Ishii1,2 (1.Division of Vaccine Science, The Institute of Medical Science, The University of Tokyo, 2.International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, 3.Laboratory of Immunoregulation and Vaccine Research, Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition)

Tomoya Tsubo1, Naganori Nao1,2,3, Katendi Changula4, Hayato Harima5, Yongjin Qiu6, Akina Mori-Kajihara1, Yoshiki Eto1, Michihito Sasaki1, Edgar Simulundu4,7, Daniel Mwizabi8, Bernard M Hangombe4,9, Hirofumi Sawa1,2,3,4, Ayato Takada1,2,4, Masahiro Kajihara1 (1.International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan, 2.One Health Research Center, Hokkaido University, Sapporo, Japan, 3.Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan, 4.School of Veterinary Medicine, the University of Zambia, Lusaka, Zambia, 5.Laboratory of Veterinary Public Health, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan, 6.Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan, 7.Macha Research Trust, Choma, Zambia, 8.Department of National Parks and Wildlife, the Ministry of Tourism and Arts, Lusaka, Zambia, 9.Africa Center of Excellence for Infectious Diseases of Humans and Animals, University of Zambia, Lusaka, Zambia)

Kentaro Uemura1,2,3,4,5, Haruaki Nobori2, Akihiko Sato2,3,6, Shinsuke Toba2,3, Shinji Kusakabe2,3, Michihito Sasaki3, Yasuko Orba3, Yoshiharu Matsuura4,5, Hirofumi Sawa3,6, Akira Matsuda7, Katsumi Maenaka1,6,7,8 (1.Faculty of Pharmaceutical Sciences, Hokkaido University, Japan, 2.Drug Discovery and Disease Research Laboratory, Shionogi & Co., Ltd., Japan, 3.International Institute for Zoonosis Control, Hokkaido University, Japan, 4.Center for Infectious Disease Education and Research, Osaka University, Japan, 5.Research Institute for Microbial Diseases, Osaka University, Japan, 6.Institute for Vaccine Research and Development, Hokkaido University, Japan, 7.Center for Research and Education on Drug Discovery, Hokkaido University, Japan, 8.Global Station for Biosurfaces and Drug Discovery, Hokkaido University, Japan)

Farzaneh Valanezhad1, Jalal Alshaweesh1, Bijay Kumar Jha2, Abhay R Satoskar3, Bradford S McGwire2 (1.Institute of Tropical Medicine, Nagasaki University, Japan, 2.Division of Infectious Disease, Department of Medicine, The Ohio State University, Columbus, Ohio, USA., 3.Department of Pathology, The Ohio State University, Columbus, Ohio, USA)

Daichi Yamasoba1,2, Izumi Kimura1, Naganori Nao3, Yusuke Kosugi1, Keiya Uriu1, Jumpei Ito1, Shinya Tanaka4, Keita Matsuno5, Hirofumi Sawa6, Takasuke Fukuhara7, Kei Sato1 (1.Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Japan, 2.Faculty of medicine, Kobe University, Japan, 3.Division of International Research Promotion, International Institute for Zoonosis Control, Hokkaido University, Japan, 4.Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Japan, 5.Division of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido University, Japan, 6.Division of Biological Response Analysis, Institute for Vaccine Research and Development, Hokkaido University, Japan, 7.Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Japan)

Reina Miyajima1, Takahiro Yamada1,2, Genshiro Sunagawa3, Takeshi Sakurai4, Koji Hase1 (1.Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Keio University, 2.Department of Immunobiology, Yale School of Medicine, 3.Laboratory for Hibernation Biology, RIKEN Center for Biosystems Dynamics Research, 4.Faculty of Medicine, University of Tsukuba)

×

Authentication

×

Please log in with your participant account.
» Participant Log In